Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Integrated BioPharma (INBP)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for INBP as compared to
Top Competitors
Drug Related Products.
Drug Related Products
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
39.4M
AVG
Wholesale Supplement Sales
►
53.8M
LOW
Number of Patents
►
18.0
R&D Expense
►
700K
VERY LOW
Revenue
Wholesale Supplement Sales
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
39.4M
AVG
EBITDA
►
-5.60M
LOW
Net Income
►
-19.4M
LOW
Revenue Growth
►
-21.2%
LOW
Operating Margin
►
-11.2%
AVG
Net Margin
►
-33.4%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-7.74
Current Ratio
►
0.804
VERY LOW
Quick Ratio
►
0.265
VERY LOW
Interest Coverage Ratio
►
-2.74
AVG
Book Value Per Share
►
-0.121
Cash Per Share
►
0.0282
Loading...
STOCK SUMMARY
Open
0.19
Day Range
0.19
-
0.19
52 Week Range
0.04
-
0.51
Volume
12K
Avg Volume (3 mo)
3K
Shares Outstanding
21.4M
Market Cap
3.85M
VALUATION
Price to Earnings (P/E)
►
-0.416
Price to Book (P/B)
►
-2.24
Price to Sales (P/S)
►
0.139
VERY LOW
Return on Assets (ROA)
►
-71.6%
VERY LOW
Return on Equity (ROE)
►
-1089.9%
VERY LOW
EV/EBITDA
►
-1.80
Dividend Yield
0%
AVG
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0.6%
Held by insiders
69.9%
Held by institutions
0%